| Date Filed | Type | Description |
| 06/16/2023 |
4
| Ragan Paula (President and CEO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 6,724 shares
@ $2.23, valued at
$15k
|
|
| 05/31/2023 |
4
| Ragan Paula (President and CEO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 6,292 shares
@ $1.95, valued at
$12.3k
|
|
| 05/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/13/2023 |
4
| Ragan Paula (President and CEO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 49,678 shares
@ $0.84, valued at
$41.7k
|
|
| 11/09/2022 |
4
| Ragan Paula (President and CEO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Granted 3,438,335 rights
@ $1.8, valued at
$6.2M
|
|
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Ragan Paula (President and CEO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 21,695 shares
@ $0 |
|
| 08/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/16/2021 |
4
| Ragan Paula (President and CEO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 13,448 shares
@ $5.78, valued at
$77.7k
|
|
| 06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2020 |
4
| Ragan Paula (President and CEO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 4,800 shares
@ $7, valued at
$33.6k
|
|
| 10/06/2020 |
4
| Ragan Paula (President and CEO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 1,797 shares
@ $7, valued at
$12.6k
|
|
| 10/05/2020 |
4
| Ragan Paula (President and CEO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 603 shares
@ $7, valued at
$4.2k
|
|
| 09/03/2020 |
4
| Ragan Paula (President and CEO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 2,400 shares
@ $7.99, valued at
$19.2k
|
|
| 08/18/2020 |
4
| Ragan Paula (President and CEO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Granted 44,826 shares
@ $0
Granted 44,825 shares
@ $0 |
|
| 08/04/2020 |
4
| Ragan Paula (President and CEO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 2,400 shares
@ $7.45, valued at
$17.9k
|
|
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2020 |
4
| Ragan Paula (President and CEO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 4,275 shares
@ $8.63, valued at
$36.9k
Sold 2,400 shares
@ $8.65, valued at
$20.8k
Sold 9,707 shares
@ $8.88, valued at
$86.2k
|
|
| 05/05/2020 |
4
| Ragan Paula (President and CEO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 2,400 shares
@ $8.92, valued at
$21.4k
|
|
| 04/03/2020 |
4
| Ragan Paula (President and CEO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 2,400 shares
@ $8.4, valued at
$20.2k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|